Piermont Capital Management Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2018$223,000
-59.7%
4,560
-80.2%
0.07%
-62.8%
Q3 2017$554,000
-38.1%
23,078
-49.6%
0.18%
-28.5%
Q2 2017$895,000
+67.6%
45,778
+47.3%
0.26%
+103.2%
Q3 2016$534,000
-37.5%
31,085
-48.3%
0.13%
-43.0%
Q2 2016$855,000
+101.2%
60,075
+94.4%
0.22%
+62.5%
Q1 2016$425,00030,9100.14%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2016
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders